Title : A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.

Pub. Date : 2010 Oct

PMID : 20690802






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer. Oxaliplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 We investigated the feasibility/efficacy of oxaliplatin in combination with trastuzumab as first-/second-line treatment of HER2-positive metastatic breast cancer (MBC). Oxaliplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens